Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and... see more

TSX:WEED - Post Discussion

Canopy Growth Corp > Food For Thought
View:
Post by Roadapples on Dec 12, 2020 2:34am

Food For Thought

This was shared a while back and I will post it again, as I like the facts and comparisons. It's not my own creation and I will not take credit for it, but it has lots of realism. Enjoy

Just some food for thought 

 

Phillip Morris a company with a 150 billion dollar market cap... 150 billion. Has an EPS of 4.18. They have 1.5 billion outstanding shares. Per quarter they are earning 1.56 billion. 

 

If Canopy had a 150 billion dollar market cap their share price would be $937 per share fully diluted. 

 

Now what are the chances Canopy makes 1.5 billion a quarter? 

 

The Canadian medical market we know is on track to be 1.5 billion in the next 2 years. Canopy controls 40% of that currently. 

 

600,000,000+ 

 

The recreational market is estimated at 5-7 billion and is also expect within 2 years. Canopy has said they want 40% of this market but let's give them 10% 

 

600,000,000 + 700,000,000 

 

The German market which is twice the size of Canada opens this year for all medical users and is expected to be covered by health insurance. A 3 billion dollar market. What percent will Canopy have?? Right now there's only a few distributers there I'd say they can capture 25% lIke they did early in the Canadian market . 

 

600,000,000 + 700,000,000 + 750,000,000 = 2.050 billion revenue. This is the start and is calculated from numbers that will happen in 2 years time 3-4 for Germany . 

 

30 % margin is 615 million. 3.84 EPS and a price per share of $96. 

 

Giving Canopy a market cap of 15 billion and making them 10% the company of Phillip Morris to start. 

 

Australia and other countries that open up excluded. Germany may take longer to reach 3 billion I think they'll have faster growth due to health insurance. Every rec user is going to be signing up there for free cannabis. Other than that these are the data points we have currently. It also shows that recreational isn't everything. 700 million rec compared to 1.4 billion medical in the next few years. We'll also see medical open up first in new countries. I'm placing my bets on medical for my investment recreational is icing on the cake. They need to Grow and grow fast. 

 

Phillip Morris EPS: A current EPS for fiscal year is observed at $4.18

Comment by Matteo1234 on Dec 12, 2020 3:02am
add in the beverages. canopy will surpass constellation brands mkt cap in the future
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities